Ensign Peak Advisors’s AnaptysBio ANAB Stock Holding History

Ensign Peak Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.23M	Sell	107,096 -18,537	-15%	-$1.12M	0.01%	492
2026 Q1	$6.97M	Sell	125,633 -89,821	-42%	-$4.83M	0.01%	475
2025 Q4	$10.4M	Hold	215,454	–	–	0.02%	399
2025 Q3	$6.6M	Hold	215,454	–	–	0.01%	542
2025 Q2	$4.78M	Hold	215,454	–	–	0.01%	653
2025 Q1	$4.01M	Hold	215,454	–	–	0.01%	685
2024 Q4	$2.85M	Buy	215,454 +139,699	+184%	+$3.38M	0.01%	804
2024 Q3	$2.54M	Hold	75,755	–	–	﹤0.01%	848
2024 Q2	$1.9M	Buy	75,755 +32,313	+74%	+$752K	﹤0.01%	934
2024 Q1	$978K	Hold	43,442	–	–	﹤0.01%	1335
2023 Q4	$931K	Hold	43,442	–	–	﹤0.01%	1429
2023 Q3	$780K	Hold	43,442	–	–	﹤0.01%	1385
2023 Q2	$884K	Hold	43,442	–	–	﹤0.01%	1363
2023 Q1	$945K	Hold	43,442	–	–	﹤0.01%	1286
2022 Q4	$1.35M	Sell	43,442 -4,800	-10%	-$136K	﹤0.01%	967
2022 Q3	$1.23M	Buy	48,242 +2,900	+6%	+$68K	﹤0.01%	966
2022 Q2	$921K	Hold	45,342	–	–	﹤0.01%	1149
2022 Q1	$1.12M	Buy	45,342 +510	+1%	+$15.4K	﹤0.01%	1131
2021 Q4	$1.56M	Buy	44,832 +1,390	+3%	+$44.1K	﹤0.01%	1063
2021 Q3	$1.18M	Buy	+43,442	New	+$1.1M	﹤0.01%	1374
2020 Q4	–	Sell	-23,005	Closed	-$339K	–	1857
2020 Q3	$339K	Buy	+23,005	New	+$415K	﹤0.01%	1600

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Ensign Peak Advisors's ANAB Position: Q2 2026 in Review

Ensign Peak Advisors reduced its AnaptysBio (ANAB) stake by 15% in Q2 2026, selling an estimated $1.12M and leaving 107,096 shares worth $7.23M. The position accounts for 0.01% of the portfolio, ranked #492.

Ensign Peak Advisors first reported a position in ANAB in Q3 2020 and has held it in 21 quarters since. The position peaked at $10.4M in Q4 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

Ensign Peak Advisors held 107,096 shares of AnaptysBio worth $7.23M as of Q2 2026.
Ensign Peak Advisors sold 18,537 AnaptysBio shares in Q2 2026, an estimated $1.12M.
AnaptysBio made up 0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #492 holding.
Ensign Peak Advisors first reported a position in AnaptysBio in Q3 2020 and has held it in 21 quarters since.
Ensign Peak Advisors's AnaptysBio position peaked at $10.4M in Q4 2025.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.